Interleukin-22: Implications for liver ischemia-reperfusion injury

Transplantation

Volumn 93, Issue 5, 2012, Pages 485-492

  Chestovich, Paul J ^a   Uchida, Yoichiro ^a,b   Chang, William ^a   Ajalat, Mark ^a   Lassman, Charles ^a   Sabat, Robert ^c   Busuttil, Ronald W ^a   Kupiec Weglinski, Jerzy W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

IL 22; Inflammation; Ischemia reperfusion injury; Liver transplantation

Indexed keywords

ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 22 ANTIBODY; INTERLEUKIN 22 RECEPTOR 1; INTERLEUKIN RECEPTOR; NEUTRALIZING ANTIBODY; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 22; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOMODULATION; LIVER CELL DAMAGE; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SCORING SYSTEM; T LYMPHOCYTE; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INTERLEUKINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 84857644131     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182449136     Document Type: Article

References (28)

1. Vardanian AJ, Busuttil RW, Kupiec-Weglinski JW. Molecular mediators of liver ischemia and reperfusion injury: A brief review. Mol Med 2008;14:337.
2. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation. Transplant Rev 1996;10:108.
3. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury-A fresh look. Exp Mol Pathol 2003;74:86.
4. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: New insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011;11:1563.
5. Zhai Y, Shen XD, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004;173:7115.
6. Shen XD, Ke B, Zhai Y, et al. Toll-like receptor and heme-oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005;5:1793.
7. Caldwell CC, Tschoep J, Lentsch AB. Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol 2007;82:457.
8. Shen X, Wang Y, Gao F, et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009;50:1537.
9. Kuboki S, Sakai N, Tschop J, et al. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2009;296:G105.
10. Wolk K, Witte E, Witte K, et al. Biology of interleukin-22. Semin Immunopathol 2010;32:17.
11. Ma HL, Liang S, Li J, et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008;118:597.
12. Ikeuchi H, Kuroiwa T, Hiramatsu N, et al. Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52:1037.
13. Wolk K, Witte E, Hoffmann U, et al. IL-22 induces lipopolysaccharidebinding protein in hepatocytes: A potential systemic role of IL-22 in Crohn's disease. J Immunol 2007;178:5973.
14. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14:275.
15. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29:947.
16. Radaeva S, Sun R, Pan HN, et al. Interleukin-22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332.
17. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. IL-22 but not IL-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007;27:647.
18. Zhai Y, Qiao B, Gao F, et al. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology 2008;47:199.
19. Wolk K, Sabat R. Interleukin 22: A novel T-and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006;17:367.
20. Park O, Wang H, Weng H, et al. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 2011;54:252.
21. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241.
22. Yang L, Zhang Y, Wang L, et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 2010;53:339.
23. Ki SH, Park O, Zheng M, et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3. Hepatology 2010;52:1291.
24. Sugimoto K, Ogawa A, Mizoguchi E, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008;118:534.
25. Brand S, Beigel F, Olszak T, et al. IL-22 is increased in active Crohn's disease and promotes pro-inflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006;290:G827.
26. Tohyama M, Hanakawa Y, Shirakata Y, et al. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression. Eur J Immunol 2009;39:2779.
27. Cherian MG, Kang YJ. Metallothionein and liver cell regeneration. Exp Biol Med 2006;231:138.
28. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al. Neutrophil accumulation as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993;55:1265.